Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.
about
Dinosaurs and ancient civilizations: reflections on the treatment of cancerPractical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretationBrain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinomaIn vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Targeted therapies in renal cell cancer: recent developments in imagingAxitinib Improves Radiotherapy in Murine Xenograft Lung Tumors.Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditionsThe changing face of renal-cell carcinoma.Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumorEvaluation of antiangiogenic effects of a new synthetic candidate drug KR-31831 on xenografted ovarian carcinoma using dynamic contrast enhanced MRI.High-field small animal magnetic resonance oncology studies.The interconnectedness of cancer cell signaling.Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture.The War on Cancer rages on.Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.Imaging of renal cell carcinoma: state of the art and recent advances.Anti-angiogenic therapy: concept to clinic.Correlation of quantitative dynamic contrast-enhanced MRI with microvascular density in necrotic, partial necrotic, and viable liver tumors in a rabbit model.Assessment of tumor response to radiation and vascular targeting therapy in mice using quantitative ultrasound spectroscopy.Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.The use of sunitinib in renal cell carcinoma: where are we now?Multiparametric MR imaging of tumor response to intraarterial chemotherapy in orthotopic xenograft models of human metastatic brain tumor.Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function.
P2860
Q24628746-F280B5DD-3E54-4C7B-ABC8-6AB08D0A9685Q30575110-EB0A5A56-1001-42E4-96AD-175FC1581AFBQ33692402-FC5F0396-D352-4733-B6D8-CF2D86980775Q33738607-18C43D2B-163F-4A8A-A953-3669BBEE3BC5Q34088696-C8CFF3C4-A10B-498B-9783-407DA7BE863EQ34092023-E73EB9F6-2A14-49AE-813A-61AB341F1B06Q34111200-15022161-0EAF-456C-9556-EE6AC7DD50D1Q34177229-0C3F800A-EA26-4F42-AD7D-5EF28D3EE370Q34246490-035F269B-E378-4F42-8EB4-AF23CC08EF04Q34331739-02F769DB-4D07-4D0B-B596-632EABF8D7CAQ34754097-9DCF00ED-34FC-4EBB-A6CD-C7F202A53443Q35201734-50055481-CB51-4CD7-848C-B5FD65AFB85AQ35312455-C0C5523D-4546-4ED4-93F3-3CD2A69FA021Q35669733-DE393251-2250-4120-9E06-B6E0F2C37155Q36270034-7BBEBC94-936F-4B0F-8FD4-38BE882D616AQ37478602-7DD57D92-DA09-49B7-AE29-34C17DF9F563Q37679045-3D7F3432-58F4-44EA-AEB8-0F3F42D9BEBFQ37819763-A7531987-1D90-4135-9254-D973FE0AAE13Q37955304-7A206399-AB50-4D05-9B93-340A53DF4B3EQ38404839-B657259D-FF2B-43B4-A5AD-878D7AF00701Q38847330-EB5C2377-3A22-4160-A079-326D7D31E265Q39141313-E4FDCC19-413C-4461-B8F6-2DF05107CF73Q48634468-B1B0476B-E74E-437C-94E3-7D37DA5E1E6DQ49022897-7894FAD8-DEEE-4F8F-813B-4DAF4303A270Q51528303-5906E04E-D30B-41F7-B6C0-F4E9E2D722A3
P2860
Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@en
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@nl
type
label
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@en
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@nl
prefLabel
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@en
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@nl
P2093
P2860
P356
P1433
P1476
Dynamic contrast-enhanced magn ...... ll carcinoma xenograft tumors.
@en
P2093
Amit D Patel
Areen K Al-Bashir
Christopher K Yunker
E Mark Haacke
Gilda G Hillman
Judith Abrams
Vinita Singh-Gupta
Yashwanth Katkuri
P2860
P304
P356
10.1593/NEO.09618
P577
2009-09-01T00:00:00Z